Neogen Corporation (NEOG)

Market Cap	1.01B
Revenue (ttm)	894.66M
Net Income (ttm)	-1.09B
Shares Out	217.21M
EPS (ttm)	-5.03
PE Ratio	n/a
Forward PE	19.02
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,055,445
Open	4.640
Previous Close	4.650
Day's Range	4.560 - 4.770
52-Week Range	3.870 - 17.955
Beta	1.77
Analysts	Buy
Price Target	7.50 (+60.94%)
Earnings Date	Jul 29, 2025

About NEOG

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residue...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Aug 23, 1989
• Employees: 2,917
• Stock Exchange: NASDAQ
• Ticker Symbol: NEOG
• Website: https://www.neogen.com

Financial Performance

In 2025, Neogen's revenue was $894.66 million, a decrease of -3.20% compared to the previous year's $924.22 million. Losses were -$1.09 billion, 11491.6% more than in 2024.

Analyst Summary

According to 3 analysts, the average rating for NEOG stock is "Buy." The 12-month stock price target is $7.5, which is an increase of 60.94% from the latest price.

Price Target

$7.5

(60.94% upside)

Analyst Consensus: Buy